Image_2_Epidemic Trends in High Tuberculosis Burden Countries During the Last Three Decades and Feasibility of Achieving the Global Targets at the Country Level.TIF by Cheng Ding (34937)

“…</p>Results<p>The incidence and mortality decreased in most of the HBCs. The AAPCs of incidence ranged between −4.0 (Indonesia) and −0.2% (DR Congo) (all p < 0.05). …”

HLA high-resolution typing by next-generation sequencing in Pandemrix-induced narcolepsy by Alexander Lind (5221088)

“…Indeed, this extended haplotype was found in 30/31 patients (96.8%) and 178/636 GP (28.0%). In total, 15 alleles, four extended haplotypes, and six genotypes were found to be increased or decreased in frequency among NT1 patients compared to GP. …”

Datasheet3_Catheter ablation vs. drug therapy in the treatment of atrial fibrillation patients with heart failure: An update meta-analysis for randomized controlled trials.docx by Chun Lin (680865)

“…According to the meta-analysis, catheter ablation significantly reduced all-cause mortality compared with drug therapy [9.2% vs. 14.1%, OR: 0.62, (95% CI: 0.47–0.82), P = 0.0007, I²= 0%], improved LVEF [MD: 5.65%, (95% CI: 3.32–7.98), P < 0.00001, I²= 86%], reduced AF recurrence [41.6% vs. 61.9%, OR: 0.23, (95% CI: 0.11–0.48), P < 0.0001, I²= 82%], decreased the MLHFQ score [MD: −6.38, (95% CI: −11.09 to −1.67), P = 0.008, I²= 64%] and increased 6MWD [MD: 17.55, (95% CI: 15.77–19.33), P < 0.0001, I²= 37%]. …”

Table1_Catheter ablation vs. drug therapy in the treatment of atrial fibrillation patients with heart failure: An update meta-analysis for randomized controlled trials.docx by Chun Lin (680865)

“…According to the meta-analysis, catheter ablation significantly reduced all-cause mortality compared with drug therapy [9.2% vs. 14.1%, OR: 0.62, (95% CI: 0.47–0.82), P = 0.0007, I²= 0%], improved LVEF [MD: 5.65%, (95% CI: 3.32–7.98), P < 0.00001, I²= 86%], reduced AF recurrence [41.6% vs. 61.9%, OR: 0.23, (95% CI: 0.11–0.48), P < 0.0001, I²= 82%], decreased the MLHFQ score [MD: −6.38, (95% CI: −11.09 to −1.67), P = 0.008, I²= 64%] and increased 6MWD [MD: 17.55, (95% CI: 15.77–19.33), P < 0.0001, I²= 37%]. …”

Datasheet2_Catheter ablation vs. drug therapy in the treatment of atrial fibrillation patients with heart failure: An update meta-analysis for randomized controlled trials.docx by Chun Lin (680865)

“…According to the meta-analysis, catheter ablation significantly reduced all-cause mortality compared with drug therapy [9.2% vs. 14.1%, OR: 0.62, (95% CI: 0.47–0.82), P = 0.0007, I²= 0%], improved LVEF [MD: 5.65%, (95% CI: 3.32–7.98), P < 0.00001, I²= 86%], reduced AF recurrence [41.6% vs. 61.9%, OR: 0.23, (95% CI: 0.11–0.48), P < 0.0001, I²= 82%], decreased the MLHFQ score [MD: −6.38, (95% CI: −11.09 to −1.67), P = 0.008, I²= 64%] and increased 6MWD [MD: 17.55, (95% CI: 15.77–19.33), P < 0.0001, I²= 37%]. …”

Datasheet4_Catheter ablation vs. drug therapy in the treatment of atrial fibrillation patients with heart failure: An update meta-analysis for randomized controlled trials.docx by Chun Lin (680865)

“…According to the meta-analysis, catheter ablation significantly reduced all-cause mortality compared with drug therapy [9.2% vs. 14.1%, OR: 0.62, (95% CI: 0.47–0.82), P = 0.0007, I²= 0%], improved LVEF [MD: 5.65%, (95% CI: 3.32–7.98), P < 0.00001, I²= 86%], reduced AF recurrence [41.6% vs. 61.9%, OR: 0.23, (95% CI: 0.11–0.48), P < 0.0001, I²= 82%], decreased the MLHFQ score [MD: −6.38, (95% CI: −11.09 to −1.67), P = 0.008, I²= 64%] and increased 6MWD [MD: 17.55, (95% CI: 15.77–19.33), P < 0.0001, I²= 37%]. …”

Datasheet1_Catheter ablation vs. drug therapy in the treatment of atrial fibrillation patients with heart failure: An update meta-analysis for randomized controlled trials.docx by Chun Lin (680865)

“…According to the meta-analysis, catheter ablation significantly reduced all-cause mortality compared with drug therapy [9.2% vs. 14.1%, OR: 0.62, (95% CI: 0.47–0.82), P = 0.0007, I²= 0%], improved LVEF [MD: 5.65%, (95% CI: 3.32–7.98), P < 0.00001, I²= 86%], reduced AF recurrence [41.6% vs. 61.9%, OR: 0.23, (95% CI: 0.11–0.48), P < 0.0001, I²= 82%], decreased the MLHFQ score [MD: −6.38, (95% CI: −11.09 to −1.67), P = 0.008, I²= 64%] and increased 6MWD [MD: 17.55, (95% CI: 15.77–19.33), P < 0.0001, I²= 37%]. …”

Dataset: Increased Organic Carbon Burial in Northern Florida Mangrove-Salt Marsh Transition Zones by Derrick Vaughn (7900301)

“…Higher amino acid concentrations in mangrove soils relative to mangrove biomass (1.8-2.3 mmol gC^-1 vs. 0.2-0.9 mmol gC^-1) and lower C/N indicated these mangrove sites receive higher algal inputs than the transition and salt marsh sites, attributed to greater tidal inundation in the mangrove sites given their position near the shoreline. …”

Dataset used in the manuscript. by Saeun Park (20410160)

“…Caregivers had more severe symptoms of depression and/or anxiety if they experienced greater changes in living situations or decreases in physical activity (CESD-20: β = 3.35, 95% CI [1.00, 5.70], p = .01), food insecurity (HSCL-25: β = 3.25, 95% CI [0.41, 6.10], p = .03, CESD-25: β = 3.09, 95% CI [0.79, 5.39], p = .01), and domestic violence (HSCL-25: β = 3.82, 95% CI [0.94, 6.70], p = .01) during COVID-19. …”

Intracellular VBNC cells maintain phenotype and viability in BMDMs. by Raffael Júnio Araújo de Castro (3875755)

“…Culturability data were expressed as means ± SD percentage of colony-forming unit (CFU) counts relative to the number of cells plated. …”

Anti-Inflammatory Cytokines Predominate in Acute Human <em>Plasmodium knowlesi</em> Infections by Janet Cox-Singh (218129)

“…Therefore pre-treatment cytokine and chemokine profiles were determined for 94 <em>P. knowlesi,</em> and for comparison, 20, <em>P. vivax</em> and 22 <em>P. falciparum,</em> patients recruited in Malaysian Borneo. …”

DataSheet_1_Preoperative immunological plasma markers TRAIL, CSF1 and TIE2 predict survival after resection for biliary tract cancer.pdf by Hannes Jansson (16390068)

“…Intratumoral TRAIL-activity was decreased compared to peritumoral immune cells, while CSF1-activity was increased. …”

Table_2_Fecal Microbial Changes in Response to Finishing Pigs Directly Fed With Fermented Feed.DOCX by Xiaopeng Tang (7355459)

“…<p>The present study investigated the effects of fermented complete feed (FCF) on fecal microbial composition during the grower-finisher period. A total of 20 pigs (Duroc × Landrace × Yorkshire, 48.74± 1.49 kg) were divided randomly into two groups: the CN group (pigs fed with a basal diet) and the FCF group (pigs fed with FCF). …”

Mutations altering LTD dynamics impair their lipid transport properties (a) Design of the STARD11-5P mutant at the omega loop (pink). by Sriraksha Srinivasan (7535654)

“…(<i>n</i> = 3; data are means ± SD; *<i>p</i> < 0.05, **<i>p</i> < 0.01; ***<i>p</i> < 0.001 [ordinary one-way ANOVA]). …”

Table_1_Fecal Microbial Changes in Response to Finishing Pigs Directly Fed With Fermented Feed.docx by Xiaopeng Tang (7355459)

“…<p>The present study investigated the effects of fermented complete feed (FCF) on fecal microbial composition during the grower-finisher period. A total of 20 pigs (Duroc × Landrace × Yorkshire, 48.74± 1.49 kg) were divided randomly into two groups: the CN group (pigs fed with a basal diet) and the FCF group (pigs fed with FCF). …”

Variation of PA/DAG ratio modulates the sensitivity and dose response of the pathway. by Jamie L. Nosbisch (8681709)

“…Colors and symbols have the same meanings as in <b><a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1007708#pcbi.1007708.g002" target="_blank">Fig 2A</a></b>. …”

Data_Sheet_1_Deciphering the mechanism of jujube vinegar on hyperlipoidemia through gut microbiome based on 16S rRNA, BugBase analysis, and the stamp analysis of KEEG.zip by Guofeng Duan (15650228)

Assessment of liver pathology in C57BL/6 mice at the end of 4 weeks of normal protein diet (NPD, control diet) or low protein diet (LPD, malnutrition diet) feeding during the first... by Prasad S. Dalvi (405608)

“…The liver triglyceride levels in the LPD-fed mice were significantly decreased post-recovery as compared with the malnutrition period (All data are presented as means ± SD, n ≥ 4 mice per group, *<i>P</i> < 0.05, ***<i>P</i><0.001, ^†††<i>P</i> < 0.001 vs. …”

K_eq and Φ of the α subunit. by Pallavi A. Bafna (271514)

“…<i>Inset,</i> The number of Φ populations (n) was estimated from the sum-squares deviation (SSQ). SSQ decreases significantly as n is increased from n = 2–5, but decreases more slowly between n = 6–20. …”

Supplemental Material for Zeiss et al., 2019 by Caroline J. Zeiss (441742)

“…</p><p>Hematoxylin and eosin, Bar = 100µm (A); 20µm (B), 50µm (C, F), 1mm (D, E)</p><p> </p><p> </p><p><b>S3 Fig 3: </b>Hematologic parameters:<b> </b>Red blood cell counts (RBC, A) decreased at the acute time point (orange) in almost all strains, except CC051. …”